Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 233,716,046 papers from all fields of science
Search
Sign In
Create Free Account
Complement 3b Receptor
Known as:
Complement 3b Receptors
, CD35 Antigens
, CD35
Expand
Molecular sites on or in some B-lymphocytes and macrophages that recognize and combine with COMPLEMENT C3B. The primary structure of these receptors…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
11 relations
CD35 Ag:PrThr:Pt:Tiss:Ord:Immune stain
CR1 wt Allele
Complement C3b
Complement Receptor Type 1
Expand
Narrower (1)
CR1L protein, human
Broader (1)
Complement Receptor
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Evolution Behavior of Carbides in 2 . 25 Cr1 Mo-0 . 25 V Steel
Zhang Yongtao
,
M. Le-de
,
W. Xiaojun
,
Zhang Hanqian
,
Li Jinfu
2009
Corpus ID: 54545186
The investigation was carried out on the evolution behavior of carbides precipitated in 2.25Cr-1Mo-0.25V steel during heat…
Expand
2005
2005
Metallographic Atlas for 2.25Cr-1Mo Steels and Degradation due to Long-term Service at the Elevated Temperatures
H. Kushima
,
Takashi Watanabe
,
M. Murata
,
K. Kamihira
,
Hideo Tanaka
,
K. Kimura
2005
Corpus ID: 29550376
In a series of Metallographic Atlas of Long-term Crept Materials as a part of NIMS Creep Data Sheet, new volume of No.M-4 on 2…
Expand
2005
2005
Approche déclarative de la modélisation de surfaces
Raphaël La Greca
2005
Corpus ID: 169934921
Nous nous interessons a la creation de surfaces a poles (NURBS essentiellement), largement utilisees dans les systemes de…
Expand
2001
2001
Analysis of Epstein-Barr Virus-binding Sites on Complement Receptor 2 ( CR 2 / CD 21 ) Using Human-Mouse Chimeras and Peptides
2001
Corpus ID: 38704299
The predicted amino acid sequence of human complement receptor 2 (CR2, CD2 1, C3d,g/Epstein-Barr virus receptor) and its genetic…
Expand
Review
1997
Review
1997
How Family-Centered Are Early Intervention Services: Staff and Parent Perceptions?.
I. Dempsey
,
A. Carruthers
1997
Corpus ID: 54711721
The 1990s has seen a dramatic shift in the desired orientation of early intervention services, involving a movement away from…
Expand
1996
1996
Neutralization of Knops system antibodies using soluble complement receptor 1
J. Moulds
,
K. E. Rowe
Transfusion
1996
Corpus ID: 24856060
BACKGROUND: Antibodies of the Knops system have been referred to as nonneutralizable because they cannot be inhibited with serum…
Expand
1994
1994
Magnetism in the spin-density-wave alloy Cr1-xMnx (x=0.007).
Sternlieb
,
Lorenzo
,
Shirane
,
Werner
,
Fawcett
Physical Review B (Condensed Matter)
1994
Corpus ID: 41301166
Neutron-scattering measurements characterizing the magnetic behavior of single-crystal Cr[sub 1[minus][ital x]]Mn[sub [ital x…
Expand
1986
1986
Identification of a nonproteolytically activated C3 with CR 1-binding properties in sera from subjects with primary biliary cirrhosis.
B. Nilsson
,
L. Lööf
,
U. Nilsson
International Archives of Allergy and Applied…
1986
Corpus ID: 1334952
Complement factor C3 associated with immune complex-like material was precipitated by 2.7% (w/v) polyethylene glycol (PEG) in…
Expand
Review
1984
Review
1984
Factors influencing the endocytosis of immune complexes.
L. van Es
,
M. Daha
Advances in nephrology from the Necker Hospital
1984
Corpus ID: 23945699
The MPS plays an important role in the removal of both particulate and soluble immunogenic material from the circulation. E.IgG…
Expand
1984
1984
Variations in expression of markers by populations of adherent cells from Trypanosoma cruzi-infected mice.
J. Wirth
,
F. Kierszenbaum
The Journal of Protozoology
1984
Corpus ID: 23727854
The kinetics of differentiation and maturation of phagocytic cells during the acute and chronic stages of experimental Chagas…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE